Global Naftopidil Tablets Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Naftopidil Tablets Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Naftopidil is an α-receptor antagonist, which can relieve the sympathetic tension of the prostate and urethra by blocking adrenaline α1 receptors, reduce urethral pressure, and improve urination disorders caused by benign prostatic hyperplasia, etc. symptom.
Naftopidil Tablets report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Naftopidil Tablets market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Retail Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Naftopidil Tablets industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Naftopidil Tablets key manufacturers include Asahi Kasei Corporation, Beijing SL Pharmaceutical Co.,Ltd., Hubei Qianjiang Pharmaceutical Co., Ltd., Shanghai Shyndec Pharmaceutical Co., Ltd., Hainan Simcere Pharmaceutical Co., Ltd., Bengbu Fengyuan Pharmaceutical Co., Ltd., GUIZHOU-EAKAN Pharmaceutical Co., Ltd., Tonghua Jitong Medical Co., Ltd. and Nanjing Meirui Pharma Co., Ltd., etc. Asahi Kasei Corporation, Beijing SL Pharmaceutical Co.,Ltd., Hubei Qianjiang Pharmaceutical Co., Ltd. are top 3 players and held % sales share in total in 2022.
Naftopidil Tablets can be divided into 25mg/tablet and 50mg/tablet, etc. 25mg/tablet is the mainstream product in the market, accounting for % sales share globally in 2022.
Naftopidil Tablets is widely used in various fields, such as Hospital, Retail Pharmacy, Clinic and Others, etc. Hospital provides greatest supports to the Naftopidil Tablets industry development. In 2022, global % sales of Naftopidil Tablets went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Naftopidil Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Asahi Kasei Corporation
Beijing SL Pharmaceutical Co.,Ltd.
Hubei Qianjiang Pharmaceutical Co., Ltd.
Shanghai Shyndec Pharmaceutical Co., Ltd.
Hainan Simcere Pharmaceutical Co., Ltd.
Bengbu Fengyuan Pharmaceutical Co., Ltd.
GUIZHOU-EAKAN Pharmaceutical Co., Ltd.
Tonghua Jitong Medical Co., Ltd.
Nanjing Meirui Pharma Co., Ltd.
Shenzhen Neptunus Pharmaceutical Co., Ltd.
Segment by Type
25mg/tablet
50mg/tablet
Hospital
Retail Pharmacy
Clinic
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Naftopidil Tablets market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Naftopidil Tablets, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Naftopidil Tablets industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Naftopidil Tablets in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Naftopidil Tablets introduction, etc. Naftopidil Tablets Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Naftopidil Tablets market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Naftopidil Tablets report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Naftopidil Tablets market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Retail Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Naftopidil Tablets industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Naftopidil Tablets key manufacturers include Asahi Kasei Corporation, Beijing SL Pharmaceutical Co.,Ltd., Hubei Qianjiang Pharmaceutical Co., Ltd., Shanghai Shyndec Pharmaceutical Co., Ltd., Hainan Simcere Pharmaceutical Co., Ltd., Bengbu Fengyuan Pharmaceutical Co., Ltd., GUIZHOU-EAKAN Pharmaceutical Co., Ltd., Tonghua Jitong Medical Co., Ltd. and Nanjing Meirui Pharma Co., Ltd., etc. Asahi Kasei Corporation, Beijing SL Pharmaceutical Co.,Ltd., Hubei Qianjiang Pharmaceutical Co., Ltd. are top 3 players and held % sales share in total in 2022.
Naftopidil Tablets can be divided into 25mg/tablet and 50mg/tablet, etc. 25mg/tablet is the mainstream product in the market, accounting for % sales share globally in 2022.
Naftopidil Tablets is widely used in various fields, such as Hospital, Retail Pharmacy, Clinic and Others, etc. Hospital provides greatest supports to the Naftopidil Tablets industry development. In 2022, global % sales of Naftopidil Tablets went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Naftopidil Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Asahi Kasei Corporation
Beijing SL Pharmaceutical Co.,Ltd.
Hubei Qianjiang Pharmaceutical Co., Ltd.
Shanghai Shyndec Pharmaceutical Co., Ltd.
Hainan Simcere Pharmaceutical Co., Ltd.
Bengbu Fengyuan Pharmaceutical Co., Ltd.
GUIZHOU-EAKAN Pharmaceutical Co., Ltd.
Tonghua Jitong Medical Co., Ltd.
Nanjing Meirui Pharma Co., Ltd.
Shenzhen Neptunus Pharmaceutical Co., Ltd.
Segment by Type
25mg/tablet
50mg/tablet
Segment by Application
Hospital
Retail Pharmacy
Clinic
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Naftopidil Tablets market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Naftopidil Tablets, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Naftopidil Tablets industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Naftopidil Tablets in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Naftopidil Tablets introduction, etc. Naftopidil Tablets Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Naftopidil Tablets market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices